GMX Vault Providers Borrow USDG Against GLV on Morpho

By Tom Whitfield

Arbitrum announced on Friday, Nov. 13 that GMX dollar-vault liquidity providers can use GLV [USDG-USDG] positions as collateral on Morpho to borrow USDG while continuing to earn GMX trading fees. The arrangement combines a fee-bearing vault position with a separate USDG borrowing, letting providers retain fee income while taking on a USDG repayment obligation.

What changes for GMX liquidity providers?

Collateral means an asset pledged to secure a loan. Here, the GLV [USDG-USDG] position backs the USDG borrowing on Morpho, while the provider keeps the vault exposure that generates GMX trading fees. The position therefore serves two functions: fee generation and loan security.

The practical effect is broader use of vault capital. Instead of withdrawing or selling a position to obtain USDG, a provider can draw USDG through Morpho and leave the GLV position in place. The announcement describes continued fee earnings as the defining benefit.

The structure resembles securing a USDG loan with an income-producing asset while retaining the asset and its fee stream. Continued fees do not make the borrowing costless or the collateral riskless.

The provider must still meet the Morpho market’s collateral and repayment conditions. The announcement did not disclose the rates or thresholds that would determine how much USDG each position supports.

Why does Arbitrum call this a continuation?

The feature builds on GMX’s earlier move to make its Dollar Vault eligible as collateral for Morpho loans. Arbitrum’s Friday, Nov. 13 announcement identifies the providers eligible to use that route, the GLV [USDG-USDG] collateral and the USDG borrowing available through it.

By connecting those elements, the update advances the integration from collateral eligibility to a defined borrowing use case. GMX provides the trading-fee-bearing vault position, Morpho hosts the lending market, and Arbitrum presents the combined workflow for GMX dollar-vault liquidity providers.

Those roles remain economically separate. Providers retain exposure to GMX trading activity through the vault and incur a USDG borrowing on Morpho. Evaluating the arrangement therefore requires the fee income, borrowing cost and collateral position to be considered together, not as a standalone return.

Where does Gauntlet fit?

Gauntlet has added the lending market to its Gauntlet USDG Premium vault. The addition links the new Morpho route to a named vault product, though the announcement does not describe how the vault selects positions or sizes its exposure.

The announcement did not explain how much capital Gauntlet allocated, whether the vault applies leverage, or how its fees and liabilities relate to the new market. It also gave no outstanding-loan or deposit figures. The confirmed fact is narrower: Gauntlet added the lending market to the Gauntlet USDG Premium vault.

The absence of sizing data leaves the commercial scale unstated. The Nov. 13 announcement does not show how many providers or dollars have used the feature, so it does not establish that the new market has become material.

What remains unresolved?

The announcement omitted several terms needed to assess utilization and downside:

• Morpho borrowing rates, origination fees and repayment terms
• Collateral ratios, liquidation thresholds and enforcement rules
• Caps on deposits, borrows and vault exposure
• Contract addresses and transaction or volume figures
• Gauntlet’s allocation policy, fee treatment and exposure accounting

Without those figures, readers cannot determine whether the new borrowing market changes GMX provider economics. The announced benefit is access to USDG while GMX trading fees continue; the cost and risk parameters remain unspecified.

What should observers watch next?

GMX trading activity and fee generation determine whether the GLV position can continue generating the described fees, while Morpho demand for USDG and Gauntlet’s vault configuration determine actual usage. Any subsequent disclosure of market sizing, borrowing terms or collateral limits will establish whether this remains a niche liquidity tool or a broader source of leveraged USDG exposure.

The next checkpoint will be any public disclosure of Morpho’s borrowing terms and Gauntlet’s allocation rules. Those figures will determine whether GLV-backed USDG borrowing becomes material or remains a limited liquidity tool.